Birdwatch Note
2023-08-18 21:50:09 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
動画に出てくるコリー氏はイベルメクチンのCOVID19の治療に有効であると主張するFLCCCのメンバーであるが2023年8月、米国内科医局は同氏対し、医療上の誤った情報を広めたとして認定を取り消すと通告した https://sciencebasedmedicine.org/the-american-board-of-internal-medicine-finally-acts-against-two-misinformation-spreading-doctors/ イベルメクチンは寄生虫感染症を治療二用いられるが、ランダム化比較試験に基づくCOVID-19の治療効果は認められない。 イベルメクチンの有効性を示した研究はin vitroまたは観察的なものであり、因果関係を証明していない https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015017.pub3/full https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2789362 https://jamanetwork.com/journals/jama/fullarticle/2777389 https://www.nejm.org/doi/full/10.1056/NEJMoa2201662
Written by 8C44BC96921239E2A14AAFE89DBC27D0FCF6DF4DBA0CA8CE63A2F475BE527858
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1692017634949439686
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1692655147598700940
- noteId - 1692655147598700940
- participantId -
- noteAuthorParticipantId - 8C44BC96921239E2A14AAFE89DBC27D0FCF6DF4DBA0CA8CE63A2F475BE527858 Participant Details
- createdAtMillis - 1692395409852
- tweetId - 1692017634949439686
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 1
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 1
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- 動画に出てくるコリー氏はイベルメクチンのCOVID19の治療に有効であると主張するFLCCCのメンバーであるが2023年8月、米国内科医局は同氏対し、医療上の誤った情報を広めたとして認定を取り消すと通告した https://sciencebasedmedicine.org/the-american-board-of-internal-medicine-finally-acts-against-two-misinformation-spreading-doctors/ イベルメクチンは寄生虫感染症を治療二用いられるが、ランダム化比較試験に基づくCOVID-19の治療効果は認められない。 イベルメクチンの有効性を示した研究はin vitroまたは観察的なものであり、因果関係を証明していない https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015017.pub3/full https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2789362 https://jamanetwork.com/journals/jama/fullarticle/2777389 https://www.nejm.org/doi/full/10.1056/NEJMoa2201662
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2023-08-18 21:50:09 UTC (1692395409852) |
2023-08-19 08:11:05 UTC (1692432665867) |
CURRENTLY_RATED_HELPFUL | 2023-08-20 02:11:21 UTC (1692497481502) |
CURRENTLY_RATED_HELPFUL | 2023-08-19 08:11:05 UTC (1692432665867) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
rated at | rated by | |
2023-08-19 17:02:26 -0500 | Rating Details | |
2023-08-19 13:54:54 -0500 | Rating Details | |
2023-08-19 09:10:44 -0500 | Rating Details | |
2023-08-19 08:11:54 -0500 | Rating Details | |
2023-08-19 07:28:23 -0500 | Rating Details | |
2023-08-19 05:57:48 -0500 | Rating Details | |
2023-08-19 05:42:06 -0500 | Rating Details | |
2023-08-19 02:19:37 -0500 | Rating Details | |
2023-08-19 02:18:14 -0500 | Rating Details | |
2023-08-19 00:23:57 -0500 | Rating Details | |
2023-08-18 23:51:46 -0500 | Rating Details | |
2023-08-18 23:49:38 -0500 | Rating Details | |
2023-08-18 23:49:32 -0500 | Rating Details | |
2023-08-18 23:21:51 -0500 | Rating Details | |
2023-08-18 22:46:23 -0500 | Rating Details | |
2023-08-18 22:30:47 -0500 | Rating Details | |
2023-08-18 22:10:18 -0500 | Rating Details | |
2023-08-18 22:02:44 -0500 | Rating Details | |
2023-08-18 22:01:51 -0500 | Rating Details | |
2023-08-18 21:53:35 -0500 | Rating Details | |
2023-08-18 21:46:15 -0500 | Rating Details | |
2023-08-18 21:33:11 -0500 | Rating Details | |
2023-08-18 21:28:54 -0500 | Rating Details | |
2023-08-18 19:10:45 -0500 | Rating Details | |
2023-08-18 18:33:02 -0500 | Rating Details | |
2023-08-18 17:24:23 -0500 | Rating Details | |
2023-08-18 17:11:22 -0500 | Rating Details | |
2023-08-18 16:59:47 -0500 | Rating Details | |
2023-08-18 16:59:26 -0500 | Rating Details | |
2023-08-18 23:52:38 -0500 | Rating Details | |
2023-08-18 21:44:54 -0500 | Rating Details | |
2023-08-18 21:27:55 -0500 | Rating Details | |
2023-08-23 06:09:52 -0500 | Rating Details | |
2023-08-24 19:25:32 -0500 | Rating Details | |
2023-08-24 19:08:36 -0500 | Rating Details | |
2023-08-24 18:37:16 -0500 | Rating Details | |
2023-08-24 09:23:11 -0500 | Rating Details | |
2023-08-25 00:40:20 -0500 | Rating Details | |
2023-08-25 00:22:25 -0500 | Rating Details | |
2023-08-24 22:40:42 -0500 | Rating Details | |
2023-08-24 22:24:45 -0500 | Rating Details | |
2023-08-24 22:24:36 -0500 | Rating Details | |
2023-08-24 20:10:08 -0500 | Rating Details | |
2024-06-01 04:46:08 -0500 | Rating Details |